Shanghai, Argo

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

Shanghai Argo Biopharmaceutical Co., Ltd. China

en | boerse | 67930135 |